Interobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast Carcinomas

Authors:

Abstract
Objectives:. Endocrine therapy reduces recurrence risk by 30% to 50% in estrogen receptor (ER)–positive breast cancer. The ER-positive threshold recomm

This publication has 18 references indexed in Scilit: